{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T13:51:59Z","timestamp":1698328319261},"reference-count":17,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-552","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T22:12:57Z","timestamp":1610748777000},"page":"201-206","source":"Crossref","is-referenced-by-count":2,"title":["Hypertrophic Cardiomyopathy Complicated by Cardiac Sarcoidosis Diagnosed by Both the Morphological Abnormalities and the Time Course of the Disease"],"prefix":"10.1536","volume":"62","author":[{"given":"Yuko","family":"Miki","sequence":"first","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Take","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Naito","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Terasaki F, Azuma A, Anzai T, <i>et al<\/i>. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - Digest version. Circ J 2019; 83: 2329-88.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsumori A, Hara M, Nagai S, <i>et al<\/i>. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000; 64: 679-83.","DOI":"10.1253\/jcj.64.679"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yazaki Y, Isobe M, Hayasaka M, Tanaka M, Fujii T, Sekiguchi M. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: Clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J 1998; 62: 465-8.","DOI":"10.1253\/jcj.62.465"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saitou T, Nagai T, Kanda S, Yoshioka K, Ikari Y. A 30-day drastic thinning of the basal interventricular septum in isolated cardiac sarcoidosis masquerading as a hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2019; 20: 65.","DOI":"10.1093\/ehjci\/jey170"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Maron MS, Finley JJ, Bos JM, <i>et al<\/i>. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008; 118: 1541-9.","DOI":"10.1161\/CIRCULATIONAHA.108.781401"},{"key":"6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/europace\/eum093","volume":"9","year":"2007","unstructured":"6. Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: Mechanisms and consequences for treatment. Europace 2007; 9: 817-22.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.80.5.1259","volume":"80","year":"1989","unstructured":"7. Fananapazir L, Tracy CM, Leon MB, <i>et al<\/i>. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989; 80: 1259-68.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"8","unstructured":"8. Rosen KL, Cameron RW, Bigham PJ, Neish SR. Hypertrophic cardiomyopathy presenting with 3rd-degree atrioventricular block. Tex Heart Inst J 1997; 24: 372-5."},{"key":"9","unstructured":"9. Przybojewski JZ, van der, Walt JJ, Ellis GC, Tiedt FA. Hypertrophic cardiomyopathy complicated by complete heart block. Case report and review of the literature. S Afr Med J 1984; 66: 847-55."},{"key":"10","unstructured":"10. Thongtang V, Panchavinin P, Chaithiraphan S. Familial hypertrophic cardiomyopathy associated with spontaneous complete heart block. J Med Assoc Thai 1991; 74: 301-5."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tamura M, Harada K, Ito T, Enoki M, Takada G. Abrupt aggravation of atrioventricular block and syncope in hypertrophic cardiomyopathy. Arch Dis Child 1995; 73: 536-7.","DOI":"10.1136\/adc.73.6.536"},{"key":"12","unstructured":"12. Desai DM, Bhat GS, Daxini BV, Sharma S. Complete heart block as a cause of syncope in hypertrophic cardiomyopathy. J Assoc Phys India 1991; 39: 965-6."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fitzgerald P, Kusumoto F. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system. J Interv Card Electrophysiol 2018; 52: 403-8.","DOI":"10.1007\/s10840-018-0433-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shimada T, Shimada K, Sakane T, <i>et al<\/i>. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-7.","DOI":"10.1016\/S0002-9343(01)00677-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 Update. J Cardiovasc Magn Reson 2020; 22: 17.","DOI":"10.1186\/s12968-020-00607-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ishida Y, Yoshinaga K, Miyagawa M, <i>et al<\/i>. Recommendations for (18) F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014; 28: 393-403.","DOI":"10.1007\/s12149-014-0806-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kumita S, Yoshinaga K, Miyagawa M, <i>et al<\/i>. Recommendations for <sup>18<\/sup>F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol 2019; 26: 1414-33.","DOI":"10.1007\/s12350-019-01755-3"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-552\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:56:39Z","timestamp":1611978999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-552\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-552","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}